News item from Vuzix:
"Vuzix has introduced a new HMD that is tailored specifically for individuals with macular degeneration, retinitis pigmentosa and other low vision problems. Apparently, preclinical trials have shown promising results, and the firm is aiming to ship 'em out en masse sometime this quarter." http://www.engadget.com/